Associated Papers
Interactions of Colorectal Cancer, Dietary Fats, and Polymorphisms of Arachidonate Lipoxygenase and Cyclooxygenase Genes: A Literature Review.
Gholamalizadeh M et al.
Frontiers in Oncology, 2022
Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine.
Zhou Y et al.
Science Advances, 2021
Association between COX2 -765G/C polymorphism and periodontitis in Chinese population: a meta-analysis.
Zhang ZS
Bmc Oral Health, 2018
Association of single nucleotide polymorphisms in MPO and COX genes with oral lichen planus.
Wu D et al.
International Journal of Immunogenetics, 2015
Association between cyclooxygenase-2 gene polymorphisms and risk of periodontitis: a meta-analysis involving 5653 individuals.
Jiang L et al.
Molecular Biology Reports, 2014
Cyclooxygenase-2 polymorphisms and susceptibility to colorectal cancer: a meta-analysis.
Wang J et al.
Yonsei Medical Journal, 2013
Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer.
Tippin BL et al.
Prostaglandins & Other Lipid Mediators, 2012
Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors.
Liu W et al.
The Pharmacogenomics Journal, 2011
A new cyclo-oxygenase-2 gene variant in the Han Chinese population is associated with an increased risk of gastric carcinoma.
Li Y et al.
Molecular Diagnosis & Therapy, 2010
Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.
Yu KD et al.
Breast Cancer Research and Treatment, 2010
Cyclooxygenase-2 Gly587Arg variant is associated with differential enzymatic activity and risk of esophageal squamous-cell carcinoma.
Zhao D et al.
Molecular Carcinogenesis, 2009
COX-2 polymorphisms -765G-->C and -1195A-->G and colorectal cancer risk.
Hoff JH et al.
World Journal of Gastroenterology, 2009
COX-2 polymorphisms and the risk for head and neck cancer in white patients.
Peters WH et al.
Head & Neck, 2009
Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available?
Pereira C et al.
European Journal of Gastroenterology & Hepatology, 2009
A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.
Cross JT et al.
The Pharmacogenomics Journal, 2008
Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the -1195G > A promoter polymorphism with mild asthma.
Shi J et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology, 2008
Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
Ueda N et al.
Cancer Science, 2008
COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk.
Mazzola S et al.
International Journal of Immunogenetics, 2007
Polymorphisms in the genes involved in the arachidonic acid-pathway, fish consumption and the risk of colorectal cancer.
Siezen CL et al.
International Journal of Cancer, 2006
Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population.
Liu F et al.
Gastroenterology, 2006
COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States).
Sansbury LB et al.
Cancer Causes & Control : Ccc, 2006
Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women.
Moorman PG et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2005
Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
Zhang X et al.
Gastroenterology, 2005
Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk.
Goodman JE et al.
Carcinogenesis, 2004
Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer.
Cox DG et al.
British Journal of Cancer, 2004
An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology.
Zhu Y et al.
Cancer Research, 2004
Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase.
Choi JH et al.
Human Genetics, 2004
Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia.
Lin HJ et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2002
Functional characterization of cyclooxygenase-2 polymorphisms.
Fritsche E et al.
The Journal of Pharmacology and Experimental Therapeutics, 2001
Genetic association studies in digestive system malignancies.
Tsigris C et al.
Anticancer Research, 0